Analysts: Acorda Therapeutics Inc (ACOR.OQ)
ACOR.OQ on NASDAQ Stock Exchange Global Select Market
37.26USD
1 Aug 2013
37.26USD
1 Aug 2013
Price Change (% chg)
$-0.71 (-1.87%)
$-0.71 (-1.87%)
Prev Close
$37.97
$37.97
Open
$37.97
$37.97
Day's High
$38.40
$38.40
Day's Low
$36.76
$36.76
Volume
187,402
187,402
Avg. Vol
112,771
112,771
52-wk High
$40.87
$40.87
52-wk Low
$21.34
$21.34
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.09 | December | 1 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 3 | 4 | 4 |
| (2) OUTPERFORM | 3 | 3 | 2 | 2 |
| (3) HOLD | 5 | 5 | 5 | 6 |
| (4) UNDERPERFORM | 1 | 1 | 1 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.33 | 2.33 | 2.25 | 2.17 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 11 | 86.76 | 91.46 | 82.00 | 82.46 |
| Quarter Ending Dec-13 | 11 | 90.44 | 98.00 | 84.00 | 88.71 |
| Year Ending Dec-13 | 11 | 331.66 | 345.19 | 316.00 | 335.35 |
| Year Ending Dec-14 | 11 | 384.70 | 415.70 | 363.30 | 381.35 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 10 | 0.09 | 0.26 | -0.05 | 0.25 |
| Quarter Ending Dec-13 | 10 | 0.09 | 0.40 | -0.08 | 0.34 |
| Year Ending Dec-13 | 10 | 0.24 | 0.84 | -0.16 | 0.98 |
| Year Ending Dec-14 | 9 | 0.91 | 1.65 | 0.01 | 1.33 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 81.05 | 71.86 | 9.18 | 11.33 |
| Quarter Ending Dec-12 | 78.90 | 81.47 | 2.57 | 3.26 |
| Quarter Ending Sep-12 | 75.20 | 77.44 | 2.24 | 2.98 |
| Quarter Ending Jun-12 | 72.55 | 75.66 | 3.11 | 4.29 |
| Quarter Ending Mar-12 | 70.96 | 71.25 | 0.28 | 0.40 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.13 | -0.03 | 0.16 | 122.30 |
| Quarter Ending Dec-12 | 0.15 | 0.01 | 0.14 | 93.26 |
| Quarter Ending Sep-12 | 0.10 | 0.24 | 0.14 | 137.86 |
| Quarter Ending Jun-12 | 0.12 | 0.11 | 0.01 | 7.56 |
| Quarter Ending Mar-12 | 0.18 | 0.25 | 0.07 | 42.45 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 86.76 | 86.76 | 87.03 | 87.27 | 82.46 |
| Quarter Ending Dec-13 | 90.44 | 90.44 | 90.62 | 90.93 | 88.71 |
| Year Ending Dec-13 | 331.66 | 331.66 | 332.57 | 333.30 | 335.35 |
| Year Ending Dec-14 | 384.70 | 384.70 | 384.70 | 386.68 | 381.35 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.09 | 0.09 | 0.09 | 0.11 | 0.25 |
| Quarter Ending Dec-13 | 0.09 | 0.09 | 0.09 | 0.11 | 0.34 |
| Quarter Ending Dec-13 | 0.24 | 0.24 | 0.27 | 0.31 | 0.98 |
| Quarter Ending Dec-14 | 0.91 | 0.86 | 0.86 | 0.97 | 1.33 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 1 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 1 | 0 | 1 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates